hIL21/hIL21R
Nomenclature
C57BL/6JSmo-Il21tm1(hIL21)Il21rtm1(hIL21R)Smoc
Cat. NO.
NM-HU-220038
Strain State
Repository Live
Model Description
Validation Data

Fig.1 Detection of IL21 expression in splenocyte by RT-PCR.
Wild type: only one band at 272 bp with primers F1/R1 (mIl21);
Homozygous: only one band at 304 bp with primers F2/R2 (hIL21);
Abbr. M, DNA marker; HO, homozygous; WT, wild type.

Fig.1 Detection of human IL21 (A) and mouse IL21(B) expression in splenocyte culture supernatants of WT C57BL/6 mice and HO hIL-21/hIL-21R mice by ELISA. Splenocytes were isolated from male 6-week-old wild-type (WT) and HO/HO hIL-21/hIL-21R mice, then seeded in 12-well plates at a density of 1×106 cells/well in 1 mL culture medium. Following in vitro stimulation with 1 μg/mL CD3 antibody and 20 ng/mL anti-mouse IL6 antibody for 72 h, IL21 levels in the culture supernatants were measured using anti-hIL21 ELISA kit and anti-mIL21 ELISA kit.
Abbr. HO, homozygous; WT, wild type; N.D. not detected.

Fig.3 Detection of IL-21R expression on T cells and B cells of of WT C57BL/6 mice and HO hIL21/hIL21R mice by FACS. Spleenocytes were collected from wild-type C57BL/6 mice (female,11 weeks old) and homozygous hIL21/hIL21R humanized mice (female,11 weeks old), and analyzed by flow cytometry with anti-mIL-21R and anti-hIL-21R.

Fig.4 Detection of IL-21R expression on T cells and B cells of of WT C57BL/6 mice and HO hIL21/hIL21R mice by FACS. Spleenocytes were collected from wild-type C57BL/6 mice (female,11 weeks old) and homozygous hIL21/hIL21R humanized mice (female,11 weeks old), stimulated with 1μg/ml anti-CD3 and 1μg/ml anti-CD28 for 48 h in vitro and analyzed by flow cytometry with anti-mIL-21R and anti-hIL-21R.

Fig.5 Human IL-21 induced the phosphorylation of Stat3 in CD3+ T cells, CD4+ T cells and CD8+ T cells in the C57BL/6 WT mouse (11 weeks old) and hIL21/hIL21R knockin mice (11 weeks old). Splenocytes were collected from the spleen, treated with different concentrations of Human IL-21 for 15 min and analyzed by flow cytometry.
You may also like
Workshop:Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreShanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more